Kumamoto K, Mitsuoka C, Izawa M, Kimura N, Otsubo N, Ishida H, Kiso M, Yamada T, Hirohashi S, Kannagi R
Program of Experimental Pathology, Aichi Cancer Center, Nagoya, 464-8681, Japan.
Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7. doi: 10.1006/bbrc.1998.8824.
Sialyl Lewis X serves as a ligand for selectins and is proposed to be implicated in hematogenous metastasis of cancers. When a cultured human breast cancer cell line, MCF-7, which does not express sialyl Lewis X, was transfected with human fucosyltransferase VI cDNA, a strong expression of sialyl Lewis X was induced on transfectant cells. The transfectant cells were found to be also reactive to the antibody NCC-ST-439, which was initially raised against human gastric cancer cells and later was shown to recognize a tumor-associated carbohydrate antigen in breast, gastric, and colon cancers. This suggested that the antigen recognized by NCC-ST-439 is closely related to sialyl Lewis X. Subsequent studies indicated that NCC-ST-439 specifically reacts to NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->6GalNAcalpha1 -->R, the sialyl Lewis X on the mucin GlcNAcbeta1-->6 GalNAcalpha structure. The antibody was not reactive to the conventional sialyl Lewis X determinants on straight and/or branched polylactosamine structures including NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->3Galbeta1-->4 Glcbeta1-->R and NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->6Galbeta1-->4 Glcbeta1-->R. This was in clear contrast to most of the known anti-sialyl Lewis X antibodies, which do not discriminate internal structures carrying the sialyl Lewis X determinant. On the other hand, the newly generated monoclonal antibody GSC154-27 had a specificity completely the reverse of the specificity of NCC-ST-439 in that it was strongly reactive to the conventional sialyl Lewis X determinants in straight and branched polylactosamine structures, while far less reactive to the sialyl Lewis X determinant on the mucin GlcNAcbeta1-->6GalNAcalpha core structure. A set of these two antibodies would be useful in discriminating the molecular species of sialyl Lewis X expressed by malignant cells and in studying their functional significance.
唾液酸化路易斯X作为选择素的配体,被认为与癌症的血行转移有关。当用人岩藻糖基转移酶VI cDNA转染不表达唾液酸化路易斯X的人乳腺癌细胞系MCF - 7时,转染细胞上诱导出了强烈的唾液酸化路易斯X表达。发现转染细胞对抗体NCC - ST - 439也有反应,该抗体最初是针对人胃癌细胞产生的,后来被证明可识别乳腺癌、胃癌和结肠癌中的一种肿瘤相关碳水化合物抗原。这表明NCC - ST - 439识别的抗原与唾液酸化路易斯X密切相关。随后的研究表明,NCC - ST - 439特异性地与NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->6GalNAcalpha1 -->R反应,即粘蛋白GlcNAcbeta1-->6 GalNAcalpha结构上的唾液酸化路易斯X。该抗体对直链和/或分支多乳糖胺结构上的传统唾液酸化路易斯X决定簇无反应,包括NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->3Galbeta1-->4 Glcbeta1-->R和NeuAcalpha2-->3Galbeta1-->4(Fucalpha1-->3)GlcNAcbet a1-->6Galbeta1-->4 Glcbeta1-->R。这与大多数已知的抗唾液酸化路易斯X抗体形成明显对比,后者不区分携带唾液酸化路易斯X决定簇的内部结构。另一方面,新产生的单克隆抗体GSC154 - 27的特异性与NCC - ST - 439完全相反,它对直链和分支多乳糖胺结构中的传统唾液酸化路易斯X决定簇有强烈反应,而对粘蛋白GlcNAcbeta1-->6GalNAcalpha核心结构上的唾液酸化路易斯X决定簇反应较弱。这两种抗体组合将有助于区分恶性细胞表达的唾液酸化路易斯X的分子种类,并研究其功能意义。